MicroRNA hsa-miR-29a-3p is a plasma biomarker for the differential diagnosis and monitoring of tuberculosis-Reference-Cited by-同舟云学术

MicroRNA hsa-miR-29a-3p is a plasma biomarker for the differential diagnosis and monitoring of tuberculosis

Published:2019-01 Issue: Volume:114 Page:69-76
ISSN:1472-9792
Container-title:Tuberculosis
language:en
Short-container-title:Tuberculosis

Author:

Ndzi Elvis Ndukong,Nkenfou Céline Nguefeu,Mekue Linda Mouafo,Zentilin Lorena,Tamgue Ousman,Pefura Eric Walter Yone,Kuiaté Jules-Roger,Giacca Mauro^ORCID,Ndjolo Alexis

Funder

International Reference Center

International Centre for Genetic Engineering and BiotechnologyInternational Centre for Genetic Engineering and Biotechnology (ICGEB)

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical),Immunology,Microbiology

Reference20 articles.

1. Robbins basic pathology;Kumar,2007

2. World Health Organization global tuberculosis report;WHO,2017

3. Global tuberculosis control: surveillance, planning;Dye,2008

4. Biomarkers and diagnostics for tuberculosis: progress, needs and translation into practice;Wallis;Lancet,2009

5. World Health Organization global tuberculosis report;WHO,2006

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Expression profiling & functional characterization of candidate miRNAs in serum exosomes among Indians with & without HIV-tuberculosis coinfection;Indian Journal of Medical Research;2024-09-07

2. Significance of extracellular vesicles in orchestration of immune responses in Mycobacterium tuberculosis infection;Frontiers in Cellular and Infection Microbiology;2024-05-21

3. miR-29 as diagnostic biomarkers for tuberculosis: a systematic review and meta-analysis;Frontiers in Public Health;2024-05-14

4. A systematic review and meta-analysis of circulating serum and plasma microRNAs in TB diagnosis;BMC Infectious Diseases;2024-04-15

5. Diagnostic value of microRNAs in active tuberculosis based on quantitative and enrichment analyses;Diagnostic Microbiology and Infectious Disease;2024-04